InBody Co.,Ltd

₩42,050As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:041830Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 3.50%
Div yield 1.43%
ROE 15.10%
Medical Devices
Beta (5Y) 0.71
PE TTM 11.79
TSR TTM 49.88%
Mkt cap ₩561.2B
ROIC 19.11%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩48,650
15.69%
(47.28%)
Hold 4|12|12|11|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
461.66
493.55
544.14
606.97
3.65%
8.12%
25.29%
37.86%
Revenue₩B
45.98
47.35
49.91
48.50
1.57%
6.47%
14.06%
11.61%
Peers (US$413.8M)
Cap (US$)
PE
578.5M
—
409.9M
13.32x
343.7M
—
411.9M
273.1x
Capital
TTM
5Y
10Y
Leveragex
0.933
0.190
0.193
EBIT/Intx
0.314
0.165
0.177
Own earn%
(154.29)
(50.75)
(43.88)
Sh yield%
40.47
30.76
33.39
Owners
Insiders/Inst%
14.83
44.36
Short interest%
4.15
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
24–28
$1 testx
—
Incr. ROIC%
4